Bayer aims to enhance performance and regain strategic flexibility by 2026

Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis

Bayer strengthens pharma portfolio with new cardiology drug acoramidis

Acquisition of exclusive commercialization rights for European markets

Healthcare Sector Skill Council organises convocation ceremony of Ayush skilled professionals

The Convocation ceremony was organized for students skilled and certified in Ayush

Dr Sheth's launches 'Healthy India Initiative’ with Doctors For You

Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers

BlueRock Therapeutics Phase I clinical trial for Parkinson’s disease continues to show positive trends

Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months

Dr Mandaviya launches AYUSH-ICMR Advanced Centre for Integrated Health Research in AIIMS

Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research

Biocon Biologics secures Canada market entry date for YESAFILI

This agreement paves the way for the introduction of YESAFILI into the Canadian market

18% of India's population needs assistive care, says former DGHS

Biocon appoints Vishal Nayyar as Head – SCM and Amit Kaptain as Head Commercials - API

Health Minister Mandaviya inaugurates 27 greenfield bulk drug park, 13 medical device manufacturing plants

PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30